Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease.
about
Molecular diagnosis of Epstein-Barr virus-related diseasesCombination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma.Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ responsePositive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relativesEBV in Hodgkin Lymphoma.Epstein-Barr virus-associated lymphomas.Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.γ-Herpesvirus load as surrogate marker of early death in HIV-1 lymphoma patients submitted to high dose chemotherapy and autologous peripheral blood stem cell transplantation.Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjectsCell-free DNA and RNA in plasma as new tools for molecular diagnostics.Evidence of an oncogenic gammaherpesvirus in domestic dogs.Natural killer-cell malignancies: diagnosis and treatment.Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancerLymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: are we there yet?Determining EBV load: current best practice and future requirements.Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile.Viruses and Hodgkin disease: no evidence of novel herpesviruses in non-EBV-associated lesions.Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimensFunctional interaction between Epstein-Barr virus replication protein Zta and host DNA damage response protein 53BP1.Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT.Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency.Human herpesvirus 8 load in matched serum and plasma samples of patients with AIDS-associated Kaposi's sarcoma.Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome.Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.Plasma Epstein Barr virus (EBV) DNA as a biomarker for EBV associated Hodgkin lymphoma.Whole blood EBV-DNA: A surrogate for immune dysfunction in aggressive lymphoma?Comparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus in peripheral blood.Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort.Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.Can a blood test monitor lymphoma?Cell-free epstein-barr viral loads in childhood hodgkin lymphoma: a study from South India.Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma.Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan.Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.Characterization of cytomegalovirus and epstein-barr virus infection in cervical lesions in Portugal.Epstein-Barr virus DNA load in peripheral blood mononuclear cells and whole blood from pediatric transplant recipients.
P2860
Q24680502-7C7B4766-8AAA-45E2-BEB0-67371E531B13Q33967422-87CE266C-9756-4671-BBF6-57E258B52F38Q34227303-10DE7B15-BFBF-4A75-B595-E72BE86CD325Q34315479-7C168E91-5239-4765-B2B2-39C114691002Q34549468-B3FB6BAF-1DD8-4348-8958-FE79C32B96C0Q34651670-75C4E2A6-C311-49F4-AA61-6AFD4D60FA39Q34769887-8CAAE953-80F4-4D0A-AAEC-17C9723553D6Q35068371-6EDB6033-750D-4F8D-899D-B4A2BD87F012Q35075563-DEBE29F5-F1C4-461B-9F93-505810D6B9AFQ35586544-51CB653C-ADE3-4694-B6C1-482D885F54F3Q35589313-761B1F44-5901-40FA-8C7F-9DECE09F5996Q36119183-222EA787-4C90-45D1-92D1-C3D3B3EA63D6Q36265596-E5170C36-B7C1-44F4-A106-2AD764E3B605Q36814594-4CDDE424-C3E8-4ADB-8F68-70AE6D2536A7Q37316016-484F3B4E-3645-4223-85FB-011EBEAE7FCEQ37373656-5D45B330-B9C2-4F24-BEC0-588CD24D245DQ37426438-22AB4012-ECC6-49CB-BB23-4528D5E41069Q38079834-63F9CA06-6989-4DC7-9D37-FE87633CD583Q38321333-933DC165-6F35-4290-905A-1F90DBBE07AEQ38363351-64DB3697-4066-42DC-BB81-0459E3F9823FQ39463952-D665F1BB-4AB3-4A69-9B07-454D8C0C1551Q39694961-5BECD779-AD63-4E4B-A7D6-4C8C90DD1FDAQ39816470-D5F7B1B0-4DAA-46CB-AA1C-B508C123B2EDQ39978862-53B9E98F-75EA-4FBF-A590-DADCB9DFC3D6Q40361558-4FD2E1A2-C6DC-4EBB-BCBD-27616D2EB0E4Q40404220-5ABCFCD2-D0E1-4DDD-8AA9-692A42B08E9FQ40605557-7C5C0AF9-4E29-4DD4-AB18-8A94C00EEEC2Q40956947-029CCE0B-C8E4-4D85-8A90-3FB85FC5177BQ40990232-FE93DFEA-AE8A-4C89-8265-787B77E56998Q41027997-F8EEF14A-4AF8-46C3-860F-ECCB9A1B6433Q41946539-4187381E-AF0C-40B1-8815-3C21CB07241FQ42257658-E240A535-E0A6-4CCF-8848-427D79AC6503Q42278089-01AF1553-A4C2-4E03-8303-7895BF89E3ECQ43035177-69CFC813-2060-45B9-8477-6E2CBB76243EQ43422047-B1DE970F-190C-48C0-80F0-0C0FF74CA136Q43765550-80CCF197-D4CB-4254-854E-3CC86645CC76Q43941355-FEA20644-0975-41BE-B2C3-0628D8986D35Q44833814-054EA116-4E81-4FBF-ABF1-65CDDAC2F4B6Q45350755-3AD15002-9CE7-42B7-B2D9-280DA530512FQ45365604-72400EC3-7EA5-497C-8984-4FA520B06402
P2860
Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Detection of Epstein-Barr viru ...... -associated Hodgkin's disease.
@en
type
label
Detection of Epstein-Barr viru ...... -associated Hodgkin's disease.
@en
prefLabel
Detection of Epstein-Barr viru ...... -associated Hodgkin's disease.
@en
P2093
P1476
Detection of Epstein-Barr viru ...... -associated Hodgkin's disease.
@en
P2093
A A Armstrong
A Gallagher
G B Clements
J MacKenzie
R F Jarrett
P304
P356
10.1002/(SICI)1097-0215(19990820)84:4<442::AID-IJC20>3.0.CO;2-J
P577
1999-08-01T00:00:00Z